Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ayumi Igaki"'
Autor:
Noriko, Hatakeda, Miho, Kuroda, Ayumi, Igaki, Seiji, Fujii, Koji, Inuzumi, Yasunao, Wada, Masahiro, Koshiba
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 59(2)
Since the auditory brainstem response (ABR) test is a test for the brainstem capacity and hearing function, it is recorded at the discharge from the neonatal intensive care unit (NICU) in our hospital. Although the reference range for the normal full
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8bb8a4e01d8d1c519a74c307126ae9e2
https://pubmed.ncbi.nlm.nih.gov/21476294
https://pubmed.ncbi.nlm.nih.gov/21476294
Autor:
Saori, Shibayama, Ayumi, Igaki, Miho, Kuroda, Michino, Honnda, Seiji, Fujii, Yasunao, Wada, Kouji, Inuzumi, Masanaka, Takeda, Masahiro, Koshiba
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 58(10)
Hashimoto's encephalopathy is regarded as an autoimmune disorder that appears in patients with anti thyroid antibodies. The thyroid function tests of the patients are not necessarily abnormal, which sometimes makes the diagnosis difficult. Since most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82bb32a19f68f76dc2e28949bdb5152c
https://pubmed.ncbi.nlm.nih.gov/21077288
https://pubmed.ncbi.nlm.nih.gov/21077288
Publikováno v:
Chemical and Pharmaceutical Bulletin. 40:255-257
The sera of diabetic patients showed an inverse correlation (r = -0.67, n = 57) between free gliclazide (oral hypoglycemic drug) level and the fructosamine value. The binding capacity of the primary binding site for gliclazide in the albumin molecule
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d892f079ea84743721964b19351d84be
https://doi.org/10.1248/cpb.40.255
https://doi.org/10.1248/cpb.40.255
Autor:
Saori Shibayama, Miho Kuroda, Fumiaki Okada, Masahiro Koshiba, Yasunao Wada, Ayumi Igaki, Tokuhide Moriyama, Koji Inuzumi, Shinichi Yoshiya, Michino Honda
Publikováno v:
Clinical Neurophysiology. 122:e10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9732a52b4449700ccecd9d8f4cfeadc
https://doi.org/10.1016/j.clinph.2011.01.016
https://doi.org/10.1016/j.clinph.2011.01.016
Autor:
Takafumi Sakoguchi, Mitsuko Shimosawa, Akira Matsuoka, Ayumi Igaki, Masako Kimura, Kunio Kobayashi
Publikováno v:
Chemicalpharmaceutical bulletin. 34(7)
Gliclazide, 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea, an oral hypoglycemic drug having the sulfonylurea structure, was completely degraded in a medium containing more than 0.2M chloride or bromide ion at 37°C after 24h. Other sulfonyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5efc27f5f9c229fdaffe319e6027a6b
https://pubmed.ncbi.nlm.nih.gov/3769097
https://pubmed.ncbi.nlm.nih.gov/3769097
Publikováno v:
Journal of chromatography. 493(1)
Fluorimetric determination of the serum sulphonylurea level after fluorination with 7-fluoro-4-nitrozobenzo-1,3-diazole. Simple extraction and rapid HPLC analysis make the method useful for routine clinical application
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29567b54f4d0b5ba3c632e3f3ad42335
https://pubmed.ncbi.nlm.nih.gov/2778016
https://pubmed.ncbi.nlm.nih.gov/2778016